Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Jun;118(3):820–825. doi: 10.1111/j.1476-5381.1996.tb15473.x

Heterogeneous distribution of benzodiazepine receptors among rat neostriatal neurones.

M Munakata 1, R Nakanishi 1, N Akaike 1
PMCID: PMC1909718  PMID: 8762113

Abstract

1. The effects of benzodiazepine receptor (BZR) agonist were investigated in dissociated rat neostriatal neurones by a conventional whole-cell patch recording configuration at room temperature. 2. The dissociated neurones, with a longest somatic diameter of larger than 25 microns, were classified as 'large neurones', while those having soma measuring less than 15 microns were described as 'small neurones'. Large neurones were intensely positive for acetylcholinesterase staining, whereas the small ones were not. 3. CL218,872 enhanced the GABA response in both the large and small neurones with similar EC50S. However, the potentiation efficacy of CL218,872 in large neurones was larger than that of small ones. 4. Zolpidem also potentiated the GABA response in both neuronal populations with similar EC50S. This compound also enhanced the GABA response more strongly in large neurones than in small ones. 5. Zopiclone exerted a prominent potentiation in large neurones, although no difference was seen in the EC50S in the large and small neurones. 6. It was concluded that the BZR in large neurones had a different pharmacological property from that in small ones and that the BZR agonists showed a prominent difference, not in EC50, but in the potentiation efficacy between these neuronal populations.

Full text

PDF
820

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Byrnes J. J., Greenblatt D. J., Miller L. G. Benzodiazepine receptor binding of nonbenzodiazepines in vivo: alpidem, zolpidem and zopiclone. Brain Res Bull. 1992 Dec;29(6):905–908. doi: 10.1016/0361-9230(92)90164-s. [DOI] [PubMed] [Google Scholar]
  2. Calabresi P., Mercuri N. B., De Murtas M., Bernardi G. Involvement of GABA systems in feedback regulation of glutamate-and GABA-mediated synaptic potentials in rat neostriatum. J Physiol. 1991;440:581–599. doi: 10.1113/jphysiol.1991.sp018726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DiFiglia M., Carey J. Large neurons in the primate neostriatum examined with the combined Golgi-electron microscopic method. J Comp Neurol. 1986 Feb 1;244(1):36–52. doi: 10.1002/cne.902440104. [DOI] [PubMed] [Google Scholar]
  4. Doble A., Martin I. L. Multiple benzodiazepine receptors: no reason for anxiety. Trends Pharmacol Sci. 1992 Feb;13(2):76–81. doi: 10.1016/0165-6147(92)90027-4. [DOI] [PubMed] [Google Scholar]
  5. Eckenstein F., Sofroniew M. V. Identification of central cholinergic neurons containing both choline acetyltransferase and acetylcholinesterase and of central neurons containing only acetylcholinesterase. J Neurosci. 1983 Nov;3(11):2286–2291. doi: 10.1523/JNEUROSCI.03-11-02286.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Faure-Halley C., Graham D., Arbilla S., Langer S. Z. Expression and properties of recombinant alpha 1 beta 2 gamma 2 and alpha 5 beta 2 gamma 2 forms of the rat GABAA receptor. Eur J Pharmacol. 1993 Aug 15;246(3):283–287. doi: 10.1016/0922-4106(93)90043-9. [DOI] [PubMed] [Google Scholar]
  7. Gao B., Fritschy J. M., Benke D., Mohler H. Neuron-specific expression of GABAA-receptor subtypes: differential association of the alpha 1- and alpha 3-subunits with serotonergic and GABAergic neurons. Neuroscience. 1993 Jun;54(4):881–892. doi: 10.1016/0306-4522(93)90582-z. [DOI] [PubMed] [Google Scholar]
  8. Gao B., Hornung J. P., Fritschy J. M. Identification of distinct GABAA-receptor subtypes in cholinergic and parvalbumin-positive neurons of the rat and marmoset medial septum-diagonal band complex. Neuroscience. 1995 Mar;65(1):101–117. doi: 10.1016/0306-4522(94)00480-s. [DOI] [PubMed] [Google Scholar]
  9. Gee K. W., Yamamura H. I. Regional heterogeneity of benzodiazepine receptors at 37 degrees C: an in vitro study in various regions of the rat brain. Life Sci. 1982 Nov 1;31(18):1939–1945. doi: 10.1016/0024-3205(82)90032-7. [DOI] [PubMed] [Google Scholar]
  10. Graveland G. A., DiFiglia M. The frequency and distribution of medium-sized neurons with indented nuclei in the primate and rodent neostriatum. Brain Res. 1985 Feb 18;327(1-2):307–311. doi: 10.1016/0006-8993(85)91524-0. [DOI] [PubMed] [Google Scholar]
  11. Groves P. M. A theory of the functional organization of the neostriatum and the neostriatal control of voluntary movement. Brain Res. 1983 Mar;286(2):109–132. doi: 10.1016/0165-0173(83)90011-5. [DOI] [PubMed] [Google Scholar]
  12. Hamill O. P., Marty A., Neher E., Sakmann B., Sigworth F. J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981 Aug;391(2):85–100. doi: 10.1007/BF00656997. [DOI] [PubMed] [Google Scholar]
  13. Im H. K., Im W. B., Hamilton B. J., Carter D. B., Vonvoigtlander P. F. Potentiation of gamma-aminobutyric acid-induced chloride currents by various benzodiazepine site agonists with the alpha 1 gamma 2, beta 2 gamma 2 and alpha 1 beta 2 gamma 2 subtypes of cloned gamma-aminobutyric acid type A receptors. Mol Pharmacol. 1993 Oct;44(4):866–870. [PubMed] [Google Scholar]
  14. Ito C., Wakamori M., Akaike N. Dual effect of glycine on isolated rat suprachiasmatic neurons. Am J Physiol. 1991 Feb;260(2 Pt 1):C213–C218. doi: 10.1152/ajpcell.1991.260.2.C213. [DOI] [PubMed] [Google Scholar]
  15. KARNOVSKY M. J., ROOTS L. A "DIRECT-COLORING" THIOCHOLINE METHOD FOR CHOLINESTERASES. J Histochem Cytochem. 1964 Mar;12:219–221. doi: 10.1177/12.3.219. [DOI] [PubMed] [Google Scholar]
  16. Kaneda M., Nakamura H., Akaike N. Mechanical and enzymatic isolation of mammalian CNS neurons. Neurosci Res. 1988 Apr;5(4):299–315. doi: 10.1016/0168-0102(88)90032-6. [DOI] [PubMed] [Google Scholar]
  17. Kawaguchi Y. Large aspiny cells in the matrix of the rat neostriatum in vitro: physiological identification, relation to the compartments and excitatory postsynaptic currents. J Neurophysiol. 1992 Jun;67(6):1669–1682. doi: 10.1152/jn.1992.67.6.1669. [DOI] [PubMed] [Google Scholar]
  18. Kawaguchi Y., Wilson C. J., Augood S. J., Emson P. C. Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci. 1995 Dec;18(12):527–535. doi: 10.1016/0166-2236(95)98374-8. [DOI] [PubMed] [Google Scholar]
  19. Laurie D. J., Wisden W., Seeburg P. H. The distribution of thirteen GABAA receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development. J Neurosci. 1992 Nov;12(11):4151–4172. doi: 10.1523/JNEUROSCI.12-11-04151.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Levey A. I., Wainer B. H., Mufson E. J., Mesulam M. M. Co-localization of acetylcholinesterase and choline acetyltransferase in the rat cerebrum. Neuroscience. 1983 May;9(1):9–22. doi: 10.1016/0306-4522(83)90042-8. [DOI] [PubMed] [Google Scholar]
  21. Lo M. M., Niehoff D. L., Kuhar M. J., Snyder S. H. Differential localization of type I and type II benzodiazepine binding sites in substantia nigra. Nature. 1983 Nov 3;306(5938):57–60. doi: 10.1038/306057a0. [DOI] [PubMed] [Google Scholar]
  22. Lüddens H., Korpi E. R., Seeburg P. H. GABAA/benzodiazepine receptor heterogeneity: neurophysiological implications. Neuropharmacology. 1995 Mar;34(3):245–254. doi: 10.1016/0028-3908(94)00158-o. [DOI] [PubMed] [Google Scholar]
  23. Maloteaux J. M., Luabeya M. A., Vanisberg M. A., Laterre E. C., Laduron P. M., Javoy-Agid F., Agid Y. Benzodiazepine receptors in normal human brain, in Parkinson's disease and in progressive supranuclear palsy. Brain Res. 1988 Apr 19;446(2):321–332. doi: 10.1016/0006-8993(88)90891-8. [DOI] [PubMed] [Google Scholar]
  24. Munakata M., Akaike N. Regulation of K+ conductance by histamine H1 and H2 receptors in neurones dissociated from rat neostriatum. J Physiol. 1994 Oct 15;480(Pt 2):233–245. doi: 10.1113/jphysiol.1994.sp020356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Murase K., Randic M., Shirasaki T., Nakagawa T., Akaike N. Serotonin suppresses N-methyl-D-aspartate responses in acutely isolated spinal dorsal horn neurons of the rat. Brain Res. 1990 Aug 13;525(1):84–91. doi: 10.1016/0006-8993(90)91323-9. [DOI] [PubMed] [Google Scholar]
  26. Murase K., Ryu P. D., Randic M. Excitatory and inhibitory amino acids and peptide-induced responses in acutely isolated rat spinal dorsal horn neurons. Neurosci Lett. 1989 Aug 14;103(1):56–63. doi: 10.1016/0304-3940(89)90485-0. [DOI] [PubMed] [Google Scholar]
  27. Nishikawa M., Munakata M., Akaike N. Muscarinic acetylcholine response in pyramidal neurones of rat cerebral cortex. Br J Pharmacol. 1994 Aug;112(4):1160–1166. doi: 10.1111/j.1476-5381.1994.tb13205.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Nishino N., Fujiwara H., Noguchi-Kuno S. A., Tanaka C. GABAA receptor but not muscarinic receptor density was decreased in the brain of patients with Parkinson's disease. Jpn J Pharmacol. 1988 Nov;48(3):331–339. doi: 10.1254/jjp.48.331. [DOI] [PubMed] [Google Scholar]
  29. Oh K. S., Lee C. J., Gibbs J. W., Coulter D. A. Postnatal development of GABAA receptor function in somatosensory thalamus and cortex: whole-cell voltage-clamp recordings in acutely isolated rat neurons. J Neurosci. 1995 Feb;15(2):1341–1351. doi: 10.1523/JNEUROSCI.15-02-01341.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Pourcher E., Bonnet A. M., Kefalos J., Dubois B., Agid Y. Effects of etybenzatropine and diazepam on levodopa-induced diphasic dyskinesias in Parkinson's disease. Mov Disord. 1989;4(3):195–201. doi: 10.1002/mds.870040301. [DOI] [PubMed] [Google Scholar]
  31. Shirasaki T., Harata N., Akaike N. Metabotropic glutamate response in acutely dissociated hippocampal CA1 pyramidal neurones of the rat. J Physiol. 1994 Mar 15;475(3):439–453. doi: 10.1113/jphysiol.1994.sp020084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sivilotti L., Nistri A. GABA receptor mechanisms in the central nervous system. Prog Neurobiol. 1991;36(1):35–92. doi: 10.1016/0301-0082(91)90036-z. [DOI] [PubMed] [Google Scholar]
  33. Squires R. F., Benson D. I., Braestrup C., Coupet J., Klepner C. A., Myers V., Beer B. Some properties of brain specific benzodiazepine receptors: new evidence for multiple receptors. Pharmacol Biochem Behav. 1979 May;10(5):825–830. doi: 10.1016/0091-3057(79)90341-1. [DOI] [PubMed] [Google Scholar]
  34. Studer L., Spenger C., Luthman J., Seiler R. W. NGF increases neuritic complexity of cholinergic interneurons in organotypic cultures of neonatal rat striatum. J Comp Neurol. 1994 Feb 8;340(2):281–296. doi: 10.1002/cne.903400212. [DOI] [PubMed] [Google Scholar]
  35. Surmeier D. J., Bargas J., Hemmings H. C., Jr, Nairn A. C., Greengard P. Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons. Neuron. 1995 Feb;14(2):385–397. doi: 10.1016/0896-6273(95)90294-5. [DOI] [PubMed] [Google Scholar]
  36. Trifiletti R. R., Snyder S. H. Anxiolytic cyclopyrrolones zopiclone and suriclone bind to a novel site linked allosterically to benzodiazepine receptors. Mol Pharmacol. 1984 Nov;26(3):458–469. [PubMed] [Google Scholar]
  37. Wafford K. A., Whiting P. J., Kemp J. A. Differences in affinity and efficacy of benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes. Mol Pharmacol. 1993 Feb;43(2):240–244. [PubMed] [Google Scholar]
  38. Wisden W., Laurie D. J., Monyer H., Seeburg P. H. The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci. 1992 Mar;12(3):1040–1062. doi: 10.1523/JNEUROSCI.12-03-01040.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Yakushiji T., Shirasaki T., Munakata M., Hirata A., Akaike N. Differential properties of type I and type II benzodiazepine receptors in mammalian CNS neurones. Br J Pharmacol. 1993 Jul;109(3):819–825. doi: 10.1111/j.1476-5381.1993.tb13648.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES